Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

Blood

Volumn 94, Issue 2, 1999, Pages 825-831

  Krijanovski, Oleg I ^b   Hill, Geoffrey R ^b   Cooke, Kenneth R ^b   Teshima, Takanori ^b   Crawford, James M ^b   Brinson, Yani S ^b   Ferrara, James L M ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; KERATINOCYTE GROWTH FACTOR; LIPOPOLYSACCHARIDE; RECOMBINANT GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT VERSUS HOST REACTION; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE ACTIVATION;

EID: 0033566285     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.825     Document Type: Article

References (34)

1. Truitt RL, Johnson BD, McCabe C, Weiler MB: Graft versus leukemia, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft-vs-Host Disease (ed 2). New York, NY, Marcel Dekker, 1997, p 385
2. Krenger W, Hill GR, Ferrara JLM: Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553, 1997
3. Ferrara JLM, Deeg HJ: Graft versus host disease. N Engl J Med 324:667, 1991
4. Hill GR, Crawford JM, Cooke KJ, Brinson YS, Pan L, Ferrara JLM: Total body irradiation effects on acute graft versus host disease. The role of gastrointestinal damage and inflammatory cytokines. Blood 90:3204, 1997
5. Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson Y, Delmonte J, Ferrara JLM: TNFα production to LPS stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 102:1882, 1998
6. Housley R, Morris C, Boyle W, Ring B, Biltz R, Tarpley J, Aukerman S, Devin P, Whitehead R, Pierce G: Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94:1764, 1994
7. Pierce G, Yanagihara D, Klopchin K, Danilenko D, Hsu E, Kenny W, Morris C: Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med 179:831, 1994
8. Panos R, Rubin J, Aaronson S, Mason R: Keratinocyte growth factor scatter factor are heparin-binding growth factors for alvealar type II cells in fibroblast-conditioned medium. J Clin Invest 92:969, 1993
9. Ulich T, Yi E, Cardiff R, Yin S, Bikhazi N, Biltz R, Morris F, Pierce G: Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. Am J Pathol 144:862, 1994
10. Yi E, Shabaik A, Lacey D, Bedoya A, Yin S, Housley R, Danilenko D, Benson W, Cohen A, Pierce G, Thomason A, Ulich T: Keratinocyte growth factor causes proliferation of urothelium in vivo. J Urol 154:1566, 1995
11. Farrell C, Bready J, Rex K, Chen J, Dipalma C, Whitcomb KL, Yin S, Hill D, Wiemann B, Starnes C, Havill A, Lu Z, Aukerman S, Pierce G, Thomasen A, Potten CS, Ulich T, Lacy D: Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58:933, 1998
12. Khan WB, Shui C, Ning S, Knox SJ: Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res 148:248, 1997
13. Frank S, Muna B, Werner S: The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene. Oncogene 14:915, 1997
14. Takeoka M, Ward W, Pollack H, Kamp D, Panos R: KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am J Physiol 272:L1174, 1997
15. Hill GR, Cooke KR, Teshima T, Crawford JM, Keith JC, Brinson YS, Bungard D, Ferrara JLM: Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic BMT. J Clin Invest 102:115, 1998
16. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Crawford JM, Ferrara JLM: An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin. Blood 88:3230, 1996
17. Snover DC, Weisdorf SA, Vercellotti GM, Rank B, Hutton S, McGlave P: A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol 16:387, 1985
18. Nestel FP, Price KS, Seemayer TA, Lapp WS: Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 175:405, 1992
19. Bajaj-Elliott M, Poulsom R, Pender SL, Wathen NC, MacDonald TT: Interactions between stromal cell derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest 102:1473, 1998
20. Egger B, Procaccimo F, Lakshmanan J, Reinshagen M, Hoffman P, Patel A, Reuben W, Gnanakkan S, Liu L, Barajas L, Eysselein VE: Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 113: 825, 1997
21. Panoskaltsis-Mortari A, Lacey DL, Vallera DA, Blazer BR: Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood 92:3960, 1998
22. Zeeh J, Procaccino F, Hoffman P, Aukerman S, McRoberts J, Soltani S, Pierce G, Lakshmanan J, Lacey D, Eysselein V: Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 110:1077, 1996
23. Hill GR, Krenger W, Ferrara JLM: Cytokine dysregulation in acute graft-versus-host disease. Hematology 2:423, 1997
24. Hattori K, Hirano T, Tateno M, Oshimi K, Kayagaki N, Yagita H, Okumura K: The synergistic effects of anti-Fas ligand and TNF-α antibody on the prevention of lethal acute graft-versus-host disease in mice. Blood 90:206, 1997
25. Mowat A: Intestinal graft versus disease, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft-vs-Host Disease (ed 2). New York, NY, Marcel Dekker, 1997, p 337
26. Garside P, Bunce C, Tomlinson RC, Nichois BL, Mowat AM: Analysis of the enteropathic effects of tumour necrosis factor α. Cytokine 5:24, 1994
27. Mowat AM, Button AK, Garside P, Steel MA: A role for IL-1α in immunoligically mediated enteropathy. Immunology 80:110, 1993
28. Tough DF, Sun S, Sprent J: T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 185:2089, 1997
29. Werner S: Keratinocyte growth factor: A unique player in epithelial repair processes. Cytokine Growth Factor Rev 9:153, 1998
30. Finch P, Cunha G, Rubin J, Wong J, Ron D: Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggest a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 203:223, 1995
31. Yang Y, Sergio JJ, Pearson D, Szot G, Shimizu A, Sykes M: Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 90:4651, 1997
32. Ning S, Shui C, Khan WB, Benson W, Lacy DL, Knox SJ: Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma lines in vitro and in vivo. Int J Radiat Oncol Biol Phys 40:177, 1998
33. Drugan CS, Stone A, Game SM, Prime SS: The mitogenic effect of KGF on cultured normal and malignant human oral keratinocytes and on contiguous fibroblasts. J Oral Pathol Med 26:327, 1997
34. Serdar C, Heard R, Prathikanti D, Lau D, Danilenko D, Hunt T, Lacey D: Safety, pharmacokinetics and biologic activity of rHuKGF in normal volunteers: Results of a placebo-controlled randomized double-blind phase 1 study. Blood 90:172, 1997 (suppl 1)